Open AccessDexmedetomidine for sedation in intensive care. Literature review and clinical experience
Author(s) -
Dmytro Dmytriiev,
Dmytro Bortnik,
Yurii Rudnitsky,
S Heranin,
Nadiia Korenchuk
Publication year - 2020
Publication title -
perioperative medicine
Language(s) - English
Resource type - Journals
eISSN - 2617-2925
pISSN - 2616-339X
DOI - 10.31636/prmd.v3i1.6
Subject(s) - dexmedetomidine , sedation , sedative , anesthesia , medicine , intensive care , agonist , analgesic , intensive care medicine , receptor
Dexmedetomidine is a fairly new and promising drug for use in intensive care and surgery. Due to the fact that it is an agonist of alpha-2-adrenoceptors, dexmedetomidine has an analgesic, sedative effect and affects hemodynamic parameters. Due to the fact that dexmedetomedin does not have the ability to suppress respiration, it is used in patients with respiratory disorders. Dexmedetomidine has minimal side effects and a wide range of uses.